SQ 33,961 IS A POTENT, LONG-ACTING, ORALLY ACTIVE THROMBOXANE RECEPTOR ANTAGONIST WITH WEAK THROMBOXANE A SYNTHASE INHIBITORY ACTIVITY

被引：0

作者：

OGLETREE, ML ^{[1
]}

HARRIS, DN ^{[1
]}

SCHUMACHER, WA ^{[1
]}

GOLDENBERG, HJ ^{[1
]}

MICHEL, IM ^{[1
]}

OKEEFE, EH ^{[1
]}

ALLEN, GT ^{[1
]}

HERAN, CL ^{[1
]}

STEINBACHER, TE ^{[1
]}

机构：

[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ

来源：

THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1143 / 1143

页数：1

共 32 条

[21] EFFECT OF BMS-180291, A LONG-ACTING THROMBOXANE A2 RECEPTOR ANTAGONIST, ON PLATELET-FUNCTION IN HEALTHY-MEN
SWANSON, BN
MANNING, JA
OGLETREE, ML
UDERMAN, H
SKOLODA, SJ
DELANEY, CL
LIAO, W
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 202 - 202
[22] A potent, orally-active, long-acting bradykinin peptide antagonist for both B1 and B2 receptors
Stewart, JM
Gera, L
Whalley, ET
Hanson, WL
Zuzack, JS
FASEB JOURNAL, 1996, 10 (03) : 3273 - 3273
[23] PANCOPRIDE, A POTENT AND LONG-ACTING 5-HT(3) RECEPTOR ANTAGONIST, IS ORALLY EFFECTIVE AGAINST ANTICANCER DRUG-EVOKED EMESIS
FERNANDEZ, AG
PUIG, J
BELETA, J
DOMENECH, T
BOU, J
BERGA, P
GRISTWOOD, RW
ROBERTS, DJ
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 222 (2-3) : 257 - 264
[24] ZATOSETRON, A POTENT, SELECTIVE, AND LONG-ACTING 5HT3 RECEPTOR ANTAGONIST - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS
ROBERTSON, DW
LACEFIELD, WB
BLOOMQUIST, W
PFEIFER, W
SIMON, RL
COHEN, ML
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (02) : 310 - 319
[25] THE SYNTHESIS OF THE CARBONYL-C-14 ANALOG OF ZATOSETRON MALEATE, A POTENT, LONG-ACTING, ORALLY EFFECTIVE 5-HT3 RECEPTOR ANTAGONIST
OBANNON, DD
WHEELER, WJ
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1991, 29 (06) : 625 - 631
[26] LY353433, a potent, orally effective, long-acting 5-HT4 receptor antagonist: Comparison to cisapride and RS23597-190
Cohen, ML
Bloomquist, W
Schaus, JM
Thompson, DC
Susemichel, AD
Calligaro, DO
Cohen, I
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (01) : 97 - 104
[27] A NOVEL SERIES OF 1-CYCLOBUTENE-3,4-DIONE DERIVATIVES WITH POTENT AND LONG-ACTING HISTAMINE-H2-RECEPTOR ANTAGONIST ACTIVITY
ALGIERI, AA
LUKE, GM
BROWN, M
STANDRIDGE, RT
PARTYKA, RA
CRENSHAW, RR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1983, 186 (AUG): : 63 - MEDI
[28] Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT2 Receptor Agonist
Varty, Geoffrey B.
Canal, Clinton E.
Mueller, Tina A.
Hartsel, Joshua A.
Tyagi, Richa
Avery, Ken
Morgan, Michael E.
Reichelt, Amy C.
Pathare, Pradip
Stang, Erik
Palfreyman, Michael G.
Nivorozhkin, Alex
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6144 - 6188
[29] A potent, long-acting, orally active (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide:: A novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors
Mitsuya, M
Kobayashi, K
Kawakami, K
Satoh, A
Ogino, Y
Kakikawa, T
Ohtake, N
Kimura, T
Hirose, H
Sato, A
Numazawa, T
Hasegawa, T
Noguchi, K
Mase, T
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) : 5017 - 5029
[30] Structural optimization affording 2-(R)-(1-(R)-3,5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist
Hale, JJ
Mills, SG
MacCoss, M
Finke, PE
Cascieri, MA
Sadowski, S
Ber, E
Chicchi, GG
Kurtz, M
Metzger, J
Eiermann, G
Tsou, NN
Tattersall, FD
Rupniak, NMJ
Williams, AR
Rycroft, W
Hargreaves, R
MacIntyre, DE
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) : 4607 - 4614

← 1 2 3 4 →